Literature DB >> 16055521

Doppler tissue imaging in assessment of pulmonary hypertension-induced right ventricle dysfunction.

Julien Boissiere1, Mathieu Gautier, Marie-Christine Machet, Gilles Hanton, Pierre Bonnet, Veronique Eder.   

Abstract

We aimed to assess the accuracy of Doppler tissue imaging (DTI) in detecting right ventricle (RV) dysfunction and electromechanical coupling alteration following pulmonary hypertension (PHT) in rat. PHT was induced by chronic hypoxia exposure (hypoxic PHT) or monocrotaline treatment (monocrotaline PHT). In both PHT models, we observed transparietal RV pressure increase and remodeling, including hypertrophy and dilation. Conventional echocardiography provided evidence for pulmonary outflow impairment with midsystolic notch and acceleration time decrease in PHT groups (21.7 +/- 1.6 and 13.2 +/- 2.9 ms in hypoxic and monocrotaline PHT groups vs. 28.1 +/- 1.0 ms in control). RV shortening fraction was decreased in the monocrotaline PHT group compared with the hypoxic PHT and control groups. Combining conventional Doppler and DTI was more helpful to detect RV diastolic dysfunction in the monocrotaline PHT group (E/Ea ratio = 17.0 +/- 1.4) compared with the hypoxic PHT and control groups (11.5 +/- 0.7 and 10.2 +/- 0.4, respectively). Tei index measured using DTI highlighted global RV dysfunction in the monocrotaline PHT group (1.36 +/- 0.24 vs. 0.92 +/- 0.05 and 0.86 +/- 0.05 in the hypoxic PHT and control groups, respectively). Q-Sm time measured from the onset of Q wave to the onset of DTI Sm wave was increased in both PHT groups. PHT-induced electromechanical coupling alteration was confirmed by in vitro activation-contraction delay measurements on isolated RV papillary muscle, and both Q-Sm time and activation-contraction delay were correlated with PHT severity. We demonstrated that Q-Sm time measured in DTI was an easily and convenient index to detect early RV electromechanical coupling alteration in both moderate and severe PHT.

Entities:  

Mesh:

Year:  2005        PMID: 16055521     DOI: 10.1152/ajpheart.00524.2005

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  13 in total

Review 1.  Do we have two hearts? New insights in right ventricular function supported by myocardial imaging echocardiography.

Authors:  Antonio Vitarelli; Claudio Terzano
Journal:  Heart Fail Rev       Date:  2010-01       Impact factor: 4.214

2.  Monocrotaline-induced pulmonary hypertension with sufficient tricuspid regurgitation in a rat model.

Authors:  Fuminobu Ishikura; Ryoko Azakami; Toshihiko Asanuma; Shintaro Beppu
Journal:  J Med Ultrason (2001)       Date:  2012-05-24       Impact factor: 1.314

3.  Prognostic effects of pulmonary hypertension in patients undergoing cardiac resynchronization therapy.

Authors:  Dongmei Wang; Yaling Han; Hongyun Zang; Haibo Yu; Shouli Wang; Zulu Wang; Quanmin Jing
Journal:  J Thorac Dis       Date:  2010-06       Impact factor: 2.895

4.  A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model.

Authors:  Juha W Koskenvuo; Rachel Mirsky; Yan Zhang; Franca S Angeli; Sarah Jahn; Tero-Pekka Alastalo; Nelson B Schiller; Andrew J Boyle; Kanu Chatterjee; Teresa De Marco; Yerem Yeghiazarians
Journal:  Int J Cardiovasc Imaging       Date:  2010-02-07       Impact factor: 2.357

5.  Elevated pulmonary artery pressure predicts poor outcome after cardiac resynchronization therapy.

Authors:  Jingfeng Wang; Yangang Su; Jin Bai; Wei Wang; Shengmei Qin; Junbo Ge
Journal:  J Interv Card Electrophysiol       Date:  2014-04-13       Impact factor: 1.900

6.  Adaptative modifications of right coronary myocytes voltage-gated K+ currents in rat with hypoxic pulmonary hypertension.

Authors:  Jean-Marc Hyvelin; Mathieu Gautier; Marie-Christine Lemaire; Pierre Bonnet; Véronique Eder
Journal:  Pflugers Arch       Date:  2008-07-17       Impact factor: 3.657

7.  Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension.

Authors:  Djuro Kosanovic; Baktybek Kojonazarov; Himal Luitel; Bhola K Dahal; Akylbek Sydykov; Teodora Cornitescu; Wiebke Janssen; Ralf P Brandes; Neil Davie; Hossein A Ghofrani; Norbert Weissmann; Friedrich Grimminger; Werner Seeger; Ralph T Schermuly
Journal:  Respir Res       Date:  2011-06-23

8.  Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial.

Authors:  Pierachille Santus; Dejan Radovanovic; Silvia Di Marco; Vincenzo Valenti; Rita Raccanelli; Francesco Blasi; Stefano Centanni; Maurizio Bussotti
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-11

9.  Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.

Authors:  Telma M Nakata; Ryou Tanaka; Rieko Yoshiyuki; Toshiharu Fukayama; Seijiro Goya; Ryuji Fukushima
Journal:  J Cardiovasc Pharmacol       Date:  2015-06       Impact factor: 3.105

10.  Rats with Chronic, Stable Pulmonary Hypertension Tolerate Low Dose Sevoflurane Inhalation as Well as Normal Rats Do.

Authors:  Xiaoqing Yin; Lu Wang; Gang Qin; Hui Luo; Xiao Liu; Fan Zhang; Zhi Ye; Junjie Zhang; E Wang
Journal:  PLoS One       Date:  2016-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.